-
strategic programme. Through multiomic and spatial biology exploration of temporally distinct samples from clinical trials and advanced biological models, an international consortium of leading colorectal
-
cancer progression, immune evasion, and therapeutic resistance. We place a strong emphasis on the use of spatial biological approaches applied to human tumour models including organ/tumour perfusion, slice
-
an industry partnered project for translational drug discovery. The role will involve analysing large scale omics and spatial datasets from both primary patient samples and advanced in vitro model systems
-
Institute for Molecular and Computational Medicine (IMCM). You will test GSK assets and targets in established models of podocyte and mesangial cell pathology relevant to glomerular diseases. You will
-
proteome in heart-specific cell lines and primary tissue. It will utilize disease model systems to characterize unique cell surface signatures for cardiomyocytes, coronary endothelial cells, and fibroblasts